share_log

昊海生物科技(06826.HK)拟8月16日举行董事会会议批准中期业绩

Haohai Biotech (06826.HK) plans to hold a board of directors meeting on August 16 to approve its mid-term performance.

Gelonghui Finance ·  Aug 6 04:40

Haohai Biotech (06826.HK) announced that the board of directors is scheduled to hold a meeting on Friday, August 16, 2024, to review and approve the company's and its subsidiaries' mid-year performance ending on June 30, 2024, and its release, as well as to consider recommending the distribution of interim dividends (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment